In a groundbreaking move, President Biden has endorsed the reclassification of cannabis, signaling a significant change in U.S. drug policy. The administration is urging federal regulators to move marijuana from Schedule I to Schedule III of the Controlled Substances Act, a change that would acknowledge its medical value and reduce criminal penalties associated with its use.

This decision comes as part of a broader effort to reform what Biden calls a “failed approach” to marijuana policy. The reclassification could have far-reaching implications, potentially easing restrictions on research and allowing cannabis businesses to access traditional banking services and tax deductions.

While the move has been welcomed by many advocates, it falls short of full legalization, which remains a contentious issue. As reported by the BBC, this policy shift reflects changing attitudes towards cannabis in the U.S. and could pave the way for further reforms in the future.